Design: Combined data from prospective cohort studies. We obtained information from four cohorts of patients receiving primary THR for osteoarthritis: Exeter Primary Outcomes Study (EPOS) Q-VD-Oph price (n = 1431); EUROHIP (n = 1327); Elective Orthopaedic Centre (n = 2832); and St. Helier (n = 787). The exposure of interest was pre-operative BMI. Confounding variables
included: age, sex, SF-36 mental health, comorbidities, fixed flexion, analgesic use, college education, OA in other joints, expectation of less pain, radiographic K&L grade, ASA grade, years of hip pain. The primary outcome was the Oxford Hip Score (OHS). Regression models describe the association of BMI on outcome adjusting for all confounders.
Results: Fora 5-unit increase in BMI, the attained 12-month OHS decreases by 0.78 points 95%CI (0.27-1.28), P-value 0.001. Compared to people of normal BMI (20-25), those in the obese class II (BMI 35-40) would have a 12-month OHS that is 2.34 points lower. Although statistically significant this effect is small and not clinically meaningful in contrast to the substantial change in OHS seen across all BMI groupings. In obese class
II patients achieved a 22.2 point change in OHS following surgery.
Conclusions: Patients achieved substantial change in OHS after THR across all BMI categories, which greatly outweighs the small difference in attained post-operative score. The findings suggest BMI should not present a barrier to access Alisertib inhibitor THR in terms of PROMs. (C) 2014 Osteoarthritis
Research Society International. Published by Elsevier Ltd. All rights reserved.”
“Sunscreens are known to play an important role on the prevention of skin cancer, as they act by blocking the carcinogenic solar radiations. The currently methods for determining the sun protection efficacy of these products are all based on in vivo tests. In this light, the aim of the present study Fer-1 was to compare the performance of two spectrophotometric in vitro methods, in order to determine which one generates more trustworthy Sun Protection Factors (SPF) values: the classical UV spectrophotometry or the diffuse transmittance reflectance spectrophotometry. For that, twenty-five SPF 30 commercial sunscreen samples were used. The methods generated different results, being the diffuse transmittance spectrophotometry more appropriate and reliable for determining the SPF of these products. Moreover, it provides as additional advantage the possibility of quantifying the protection against UVA radiation through the UVA/UVB Ratio and the Critical Wavelength.
No related posts.